{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T13:30:15Z","timestamp":1749043815406},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T00:00:00Z","timestamp":1414540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00066-014-0775-1","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T02:22:30Z","timestamp":1414462950000},"page":"242-247","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Modulation of radiation-induced oral mucositis by pentoxifylline: Preclinical studies"],"prefix":"10.1007","volume":"191","author":[{"given":"Sylvia","family":"Gruber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margret","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Bozsaky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Wolfram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Haagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Habelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Puttrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"775_CR1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00066-013-0481-4","volume":"190","author":"V Budach","year":"2014","unstructured":"Budach V, Becker ET, Boehmer D et al (2014) Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer. The 10-year results of a prospective phase II trial. Strahlenther Onkol 190:250\u2013255","journal-title":"Strahlenther Onkol"},{"key":"775_CR2","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/cncr.23898","volume":"113","author":"LS Elting","year":"2008","unstructured":"Elting LS, Keefe DM, Sonis ST et al (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113:2704\u20132713","journal-title":"Cancer"},{"key":"775_CR3","first-page":"13","volume":"5","author":"BA Murphy","year":"2007","unstructured":"Murphy BA (2007) Clinical and economic consequences of mucositis induced by chemotherapy and\/or radiation therapy. J Support Oncol 5:13\u201321","journal-title":"J Support Oncol"},{"key":"775_CR4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00066-013-0311-8","volume":"189","author":"A Wygoda","year":"2013","unstructured":"Wygoda A, Rutkowski T, Hutnik M et al (2013) Acute mucosal reactions in patients with head and neck cancer. Three patterns of mucositis observed during radiotherapy. Strahlenther Onkol 189:547\u2013551","journal-title":"Strahlenther Onkol"},{"key":"775_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cden.2007.10.002","volume":"52","author":"RV Lalla","year":"2008","unstructured":"Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients who have cancer. Dent Clin North Am 52:61\u201377, viii","journal-title":"Dent Clin North Am"},{"key":"775_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.radonc.2013.03.007","volume":"106","author":"R Butof","year":"2013","unstructured":"Butof R, Baumann M (2013) Time in radiation oncology\u2014keep it short! Radiother Oncol 106:271\u2013275","journal-title":"Radiother Oncol"},{"key":"775_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0360-3016(92)90768-D","volume":"23","author":"JF Fowler","year":"1992","unstructured":"Fowler JF, Lindstrom MJ (1992) Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23:457\u2013467","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"775_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00066-005-1331-9","volume":"181","author":"T Herrmann","year":"2005","unstructured":"Herrmann T, Baumann M (2005) Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation. Strahlenther Onkol 181:65\u201376","journal-title":"Strahlenther Onkol"},{"key":"775_CR9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0167-8140(01)00429-7","volume":"61","author":"W Dorr","year":"2001","unstructured":"Dorr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61:223\u2013231","journal-title":"Radiother Oncol"},{"key":"775_CR10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/0022034514540174","volume":"93","author":"CT Viet","year":"2014","unstructured":"Viet CT, Corby PM, Akinwande A et al (2014) Review of preclinical studies on treatment of mucositis and associated pain. J Dent Res 93:868\u2013875","journal-title":"J Dent Res"},{"key":"775_CR11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","volume":"68","author":"LS Elting","year":"2007","unstructured":"Elting LS, Cooksley CD, Chambers MS et al (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68:1110\u20131120","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"775_CR12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.22484","volume":"109","author":"DM Keefe","year":"2007","unstructured":"Keefe DM, Schubert MM, Elting LS et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820\u2013831","journal-title":"Cancer"},{"key":"775_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semradonc.2008.09.006","volume":"19","author":"DI Rosenthal","year":"2009","unstructured":"Rosenthal DI, Trotti A (2009) Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 19:29\u201334","journal-title":"Semin Radiat Oncol"},{"key":"775_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOO.0b013e3280523ad6","volume":"15","author":"N Treister","year":"2007","unstructured":"Treister N, Sonis S (2007) Mucositis: biology and management. Curr Opin Otolaryngol Head Neck Surg 15:123\u2013129","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"775_CR15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00066-014-0637-x","volume":"190","author":"P Maier","year":"2014","unstructured":"Maier P, Wenz F, Herskind C (2014) Radioprotection of normal tissue cells. Strahlenther Onkol 190:745\u2013752","journal-title":"Strahlenther Onkol"},{"key":"775_CR16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ctrv.2007.03.001","volume":"33","author":"RM Logan","year":"2007","unstructured":"Logan RM, Stringer AM, Bowen JM et al (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33:448\u2013460","journal-title":"Cancer Treat Rev"},{"key":"775_CR17","first-page":"3","volume":"5","author":"ST Sonis","year":"2007","unstructured":"Sonis ST (2007) Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 5:3\u201311","journal-title":"J Support Oncol"},{"key":"775_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/oxfordjournals.jncimonographs.a003435","volume":"29","author":"DA Williams","year":"2001","unstructured":"Williams DA (2001) Inflammatory cytokines and mucosal injury. J Natl Cancer Inst Monogr 29:26\u201330","journal-title":"J Natl Cancer Inst Monogr"},{"key":"775_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/RCT.0b013e31828aed3f","volume":"37","author":"N Saito","year":"2013","unstructured":"Saito N, Truong MT, Qureshi MM et al (2013) Correlation of mucositis during head and neck radiotherapy with computed tomography perfusion imaging of the oropharyngeal mucosa. J Comput Assist Tomogr 37:499\u2013504","journal-title":"J Comput Assist Tomogr"},{"key":"775_CR20","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1007\/s00520-013-1884-6","volume":"21","author":"SB Jensen","year":"2013","unstructured":"Jensen SB, Jarvis V, Zadik Y et al (2013) Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Support Care Cancer 21:3223\u20133232","journal-title":"Support Care Cancer"},{"key":"775_CR21","doi-asserted-by":"crossref","unstructured":"Worthington HV, Clarkson JE, Eden OB (2007) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 3:CD000978","DOI":"10.1002\/14651858.CD000978.pub3"},{"key":"775_CR22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","volume":"34","author":"A Ward","year":"1987","unstructured":"Ward A, Clissold SP (1987) Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34:50\u201397","journal-title":"Drugs"},{"key":"775_CR23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/aid.2011.0385","volume":"28","author":"LA Green","year":"2012","unstructured":"Green LA, Kim C, Gupta SK et al (2012) Pentoxifylline reduces tumor necrosis factor-alpha and HIV-induced vascular endothelial activation. AIDS Res Hum Retroviruses 28:1207\u20131215","journal-title":"AIDS Res Hum Retroviruses"},{"key":"775_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2011.04.030","volume":"662","author":"TC Peterson","year":"2011","unstructured":"Peterson TC, Peterson MR, Raoul JM (2011) The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis. Eur J Pharmacol 662:47\u201354","journal-title":"Eur J Pharmacol"},{"key":"775_CR25","first-page":"427","volume":"34","author":"Q Ji","year":"2004","unstructured":"Ji Q, Zhang L, Jia H et al (2004) Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines. Ann Clin Lab Sci 34:427\u2013436","journal-title":"Ann Clin Lab Sci"},{"key":"775_CR26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2249.2001.01546.x","volume":"124","author":"T Samardzic","year":"2001","unstructured":"Samardzic T, Jankovic V, Stosic-Grujicic S et al (2001) Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18. Clin Exp Immunol 124:274\u2013281","journal-title":"Clin Exp Immunol"},{"key":"775_CR27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/095530000138727","volume":"76","author":"W Dorr","year":"2000","unstructured":"Dorr W, Brankovic K, Hartmann B (2000) Repopulation in mouse oral mucosa: changes in the effect of dose fractionation. Int J Radiat Biol 76:383\u2013390","journal-title":"Int J Radiat Biol"},{"key":"775_CR28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00066-013-0510-3","volume":"190","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Haagen J, Noack R et al (2014) Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation. Strahlenther Onkol 190:399\u2013404","journal-title":"Strahlenther Onkol"},{"key":"775_CR29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/09553000500196136","volume":"81","author":"W Dorr","year":"2005","unstructured":"Dorr W, Heider K, Spekl K (2005) Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF. Int J Radiat Biol 81:557\u2013565","journal-title":"Int J Radiat Biol"},{"key":"775_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2004.12.006","volume":"75","author":"W Dorr","year":"2005","unstructured":"Dorr W, Reichel S, Spekl K (2005) Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiother Oncol 75:99\u2013105","journal-title":"Radiother Oncol"},{"key":"775_CR31","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00520-013-1810-y","volume":"21","author":"N Al-Dasooqi","year":"2013","unstructured":"Al-Dasooqi N, Sonis ST, Bowen JM et al (2013) Emerging evidence on the pathobiology of mucositis. Support Care Cancer 21:2075\u20132083","journal-title":"Support Care Cancer"},{"key":"775_CR32","first-page":"262","volume":"83","author":"P Neuner","year":"1994","unstructured":"Neuner P, Klosner G, Schauer E et al (1994) Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology 83:262\u2013267","journal-title":"Immunology"},{"key":"775_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-3083.2006.001761.x","volume":"63","author":"G Gutierrez-Reyes","year":"2006","unstructured":"Gutierrez-Reyes G, Lopez-Ortal P, Sixtos S et al (2006) Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis C. Scand J Immunol 63:461\u2013467","journal-title":"Scand J Immunol"},{"key":"775_CR34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00280-007-0534-4","volume":"61","author":"ML Melo","year":"2008","unstructured":"Melo ML, Brito GA, Soares RC et al (2008) Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Cancer Chemother Pharmacol 61:775\u2013784","journal-title":"Cancer Chemother Pharmacol"},{"key":"775_CR35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0722.2005.00216.x","volume":"113","author":"V Lima","year":"2005","unstructured":"Lima V, Brito GA, Cunha FQ et al (2005) Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters. Eur J Oral Sci 113:210\u2013217","journal-title":"Eur J Oral Sci"},{"key":"775_CR36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/095530097142780","volume":"72","author":"W Dorr","year":"1997","unstructured":"Dorr W (1997) Three A's of repopulation during fractionated irradiation of squamous epithelia: asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions. Int J Radiat Biol 72:635\u2013643","journal-title":"Int J Radiat Biol"},{"key":"775_CR37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/09553002310001600925","volume":"79","author":"W Dorr","year":"2003","unstructured":"Dorr W (2003) Modulation of repopulation processes in oral mucosa: experimental results. Int J Radiat Biol 79:531\u2013537","journal-title":"Int J Radiat Biol"},{"key":"775_CR38","doi-asserted-by":"crossref","unstructured":"D\u00f6rr W (2009) Pathogenesis of normal tissue side effects. In: Joiner M Van der Kogel A (ed) Basic Clinical Radiobiology. Hodder Arnold, London, pp\u00a0169\u2013190","DOI":"10.1201\/b13224-14"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-014-0775-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-014-0775-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-014-0775-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T14:28:49Z","timestamp":1565965729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-014-0775-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1007\/s00066-014-0775-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}